Mullerian adenosarcoma of the uterus is a biphasic tumor exhibiting benign
epithelial and malignant stromal component. This tumor may occasionally be
associated with tamoxifen therapy which is used as an adjuvant drug for bre
ast carcinoma. Reviewing the literature, we found only 12 adenosarcoma case
s associated with tamoxifen therapy Thus, the clinical and pathological fin
dings in a 58 years old postmenopausal woman who developed uterine adenosar
coma, following low dose tamoxifen therapy after 8 years, was discussed in
this report.